Promethera

is a biopharmaceutical company that develops and commercializes novel cell-based therapies for the treatment of chronic liver diseases...
Read more
Promethera Chairman: Etienne Sokal

Chairman

Etienne Sokal

CEO Approval Rating

90/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$145.4M
Acquisitions
2

Promethera Competitors

1Dicerna
2Ambys
3CymaBay
4Alentis
5Liver Specialists Of Texas
6iTeos
7Dimension Therapeutics
8Celyad
9Juno Therapeutics
10bluebird bio

Trending Companies